The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. (2012)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/ni.2260

PubMed Identifier: 22447028

Publication URI: http://europepmc.org/abstract/MED/22447028

Type: Journal Article/Review

Volume: 13

Parent Publication: Nature immunology

Issue: 5

ISSN: 1529-2908